Crossmark

Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I–II trial of radiotherapy/tipifarnib combination

Crossref DOI link: https://doi.org/10.1007/s11060-015-1860-8

Published Online: 2015-07-19

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ken, Soléakhéna

Deviers, Alexandra

Filleron, Thomas

Catalaa, Isabelle

Lotterie, Jean-Albert

Khalifa, Jonathan

Lubrano, Vincent

Berry, Isabelle

Péran, Patrice

Celsis, Pierre

Moyal, Elizabeth Cohen-Jonathan

Laprie, Anne
License Information

Text and Data Mining valid from 2015-07-19